¹Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
²Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
³Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
⁴Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
⁵Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
⁶Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA.
⁷Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
⁸Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Québec, Canada.
⁹Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Québec, Canada.
¹⁰Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹¹Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
¹²Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
¹³Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
¹⁴Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹⁵Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹⁶Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹⁷Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands.
¹⁸Center for Inherited Disease Research (CIDR), Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
¹⁹Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK.
²⁰Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), IRCCS, Padua, Italy.
²¹Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
²²Center for Cancer Epidemiology and Prevention, University of Chicago, Chicago, Illinois, USA.
²³Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
²⁴Personalised Medicine Team, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
²⁵Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
²⁶Roswell Park Cancer Institute, Buffalo, New York, USA.
²⁷Center for Genomic Medicine, Department of Biomedical Data Science, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA.
²⁸Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
²⁹Department of Epidemiology, University of California, Irvine, Irvine, California, USA.
³⁰N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
³¹Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
³²Institute of Clinical Molecular Biology / Department of Gynecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.
³³Department of Public Health Sciences and Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.
³⁴Institute of Human Genetics, Hannover Medical School, Hannover, Germany.
³⁵Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
³⁶Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands.
³⁷Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori (INT), Milan, Italy.
³⁸McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada.
³⁹Department of Medical Oncology, University Hospital, Vall d'Hebron, Barcelona, Spain.
⁴⁰Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy.
⁴¹Bâtiment Cheney D, Centre Léon Bérard, Lyon, France.
⁴²Laboratory of Cell Biology, Department of Pathology, Landspitali, Reykjavik, Iceland.
⁴³Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁴⁴Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
⁴⁵Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
⁴⁶Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
⁴⁷Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
⁴⁸Human Genotyping Unit -Centro Nacional de Genotipado (CEGEN), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
⁴⁹Institute of Biochemistry and Genetics, Ufa Scientific Center of the Russian Academy of Sciences, Ufa, Russian Federation.
⁵⁰Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA.
⁵¹Université Clermont Auvergne, INSERM, U1240, Imagerie Moléculaire et Stratégies Théranostiques, Centre Jean Perrin, Clermont-Ferrand, France.
⁵²Clinical Cancer Genetics, City of Hope, Duarte, California, USA.
⁵³Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands.
⁵⁴Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
⁵⁵Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
⁵⁶City of Hope Clinical Cancer Genomics Community Research Network, Duarte, California, USA.
⁵⁷Vesalius Research Center, VIB, Leuven, Belgium.
⁵⁸N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
⁵⁹Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.
⁶⁰Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
⁶¹Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy.
⁶²Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
⁶³Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
⁶⁴Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁶⁵Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁶⁶Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
⁶⁷Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁶⁸Gustave Roussy, Biopathology Department, Villejuif, France.
⁶⁹Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK.
⁷⁰Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
⁷¹Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
⁷²Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada.
⁷³Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, Girona, Spain.
⁷⁴Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany.
⁷⁵Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
⁷⁶Department of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah, USA.
⁷⁷Center for Genomic Medicine, Department of Biomedical Data Science, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA.
⁷⁸Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
⁷⁹Medical Oncology Department, CIBERONC, Hospital Clínico San Carlos, Madrid, Spain.
⁸⁰Section of Molecular Genetics, Department of Laboratory Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy.
⁸¹Research Department, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
⁸²Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁸³Gustave Roussy, Biopathology Department, Villejuif, France.
⁸⁴Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servizo Galego de Saúde SERGAS, Santiago de Compostela, Spain.
⁸⁵Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA.
⁸⁶Oncology and Genetics Unit, Instituto de Investigación Biomédica (IBI) de Orense-Pontevedra-Vigo, Xerencia de Xestión Integrada de Vigo, Servizo Galego de Saúde SERGAS, Vigo, Spain.
⁸⁷Centre François Baclesse, Caen, France.
⁸⁸Service de Génétique Oncologique and INSERM U830, Institut Curie, Paris, France - Université Paris Descartes, Sorbonne Paris Cité.
⁸⁹Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁹⁰Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
⁹¹Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
⁹²Division of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Buffalo, New York, USA.
⁹³Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec City, Québec, Canada.
⁹⁴Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
⁹⁵Center for Medical Genetics, Ghent University, Ghent, Belgium.
⁹⁶Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
⁹⁷Huntsman Cancer Institute, Salt Lake City, Utah, USA.
⁹⁸Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
⁹⁹Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK.
¹⁰⁰Cancer and Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.
¹⁰¹Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
¹⁰²Unité d'Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France.
¹⁰³Academic Unit of Molecular Oncology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
¹⁰⁴Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
¹⁰⁵Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK.
¹⁰⁶Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
¹⁰⁷Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
¹⁰⁸Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
¹⁰⁹Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
¹¹⁰Bâtiment Cheney D, Centre Léon Bérard, Lyon, France.
¹¹¹Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
¹¹²Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK.
¹¹³Center for Medical Genetics, Ghent University, Ghent, Belgium.
¹¹⁴Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
¹¹⁵Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
¹¹⁶Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Clinical and Molecular Genetics Area, Vall d'Hebron University Hospital, Barcelona, Spain.
¹¹⁷Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA.
¹¹⁸Department of Gynecology and Obstetrics, Ludwig Maximilians University of Munich, Munich, Germany.
¹¹⁹Center for Inherited Disease Research (CIDR), Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
¹²⁰Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
¹²¹Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa.
¹²²Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
¹²³Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
¹²⁴Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Québec, Canada.
¹²⁵Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
¹²⁶Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Québec, Canada.
¹²⁷Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
¹²⁸Southampton Clinical Trials Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
¹²⁹Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK.
¹³⁰Institute of Human Genetics, University of Münster, Münster, Germany.
¹³¹Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
¹³²Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.
¹³³Department of Clinical Genetics, Lund University Hospital, Lund, Sweden.
¹³⁴Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
¹³⁵Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
¹³⁶Institute of Human Genetics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
¹³⁷Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
¹³⁸Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
¹³⁹Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
¹⁴⁰Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
¹⁴¹Genetics Department, Dijon University Hospital, Dijon, France.
¹⁴²Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
¹⁴³Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
¹⁴⁴Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
¹⁴⁵Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
¹⁴⁶Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
¹⁴⁷Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
¹⁴⁸Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, Québec, Canada.
¹⁴⁹Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel.
¹⁵⁰School of Public Health, Curtin University, Perth, Western Australia, Australia.
¹⁵¹Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹⁵²Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
¹⁵³Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
¹⁵⁴Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
¹⁵⁵Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Schools of Medicine and Public Health, University of California, Los Angeles, Los Angeles, California, USA.
¹⁵⁶Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA.
¹⁵⁷Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
¹⁵⁸Medical Oncology Department, CIBERONC, Hospital Clínico San Carlos, Madrid, Spain.
¹⁵⁹Medical Oncology Department, CIBERONC, Hospital Clínico San Carlos, Madrid, Spain.
¹⁶⁰Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA.
¹⁶¹Service de Génétique Oncologique and INSERM U830, Institut Curie, Paris, France - Université Paris Descartes, Sorbonne Paris Cité.
¹⁶²Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany.
¹⁶³Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece.
¹⁶⁴Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark.
¹⁶⁵Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
¹⁶⁶Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
¹⁶⁷Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
¹⁶⁸Department of Medicine, McGill University, Montréal, Québec, Canada.
¹⁶⁹Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA.
¹⁷⁰Human Genotyping Unit -Centro Nacional de Genotipado (CEGEN), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
¹⁷¹Department of Obstetrics and Gynecology, Ohio State University James Comprehensive Cancer Center, Columbus, Ohio, USA.
¹⁷²Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, USA.
¹⁷³Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
¹⁷⁴Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland.
¹⁷⁵Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
¹⁷⁶Centre de Recherche du Centre Hospitalier de Université de Montréal (CHUM), Montréal, Québec, Canada.
¹⁷⁷Department of Obstetrics and Gynaecology and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.
¹⁷⁸Cancer and Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.
¹⁷⁹Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹⁸⁰Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
¹⁸¹Center for Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
¹⁸²Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
¹⁸³Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
¹⁸⁴Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
¹⁸⁵Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
¹⁸⁶McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada.
¹⁸⁷Department of Biostatistics and Epidemiology, University of Massachusetts, Amherst, Amherst, Massachusetts, USA.
¹⁸⁸Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
¹⁸⁹Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
¹⁹⁰Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
¹⁹¹Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.
¹⁹²Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
¹⁹³Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
¹⁹⁴Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
¹⁹⁵Institute of Genetic Medicine, Centre for Life, Newcastle-upon-Tyne Hospitals NHS Trust, Newcastle-upon-Tyne, UK.
¹⁹⁶School of Population Health, University of Western Australia, Perth, Western Australia, Australia.
¹⁹⁷Cancer Genomics Research Laboratory (CGR), Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
¹⁹⁸Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
¹⁹⁹Medical Genetics Unit, St George's, University of London, London, UK.
²⁰⁰Family Cancer Clinic, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
²⁰¹Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
²⁰²Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
²⁰³Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
²⁰⁴Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
²⁰⁵Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
²⁰⁶Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
²⁰⁷Center for Medical Genetics, NorthShore University HealthSystem, Evanston, Illinois, USA.
²⁰⁸Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
²⁰⁹Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
²¹⁰N.N. Petrov Institute of Oncology, St. Petersburg, Russian Federation.
²¹¹Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
²¹²Division of Epidemiology, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
²¹³Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
²¹⁴Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
²¹⁵Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
²¹⁶State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.
²¹⁷Department of Gynaecology and Obstetrics, University of Ulm, Ulm, Germany.
²¹⁸Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
²¹⁹Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, USA.
²²⁰Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
²²¹Cancer Genomics Research Laboratory (CGR), Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
²²²Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
²²³Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland.
²²⁴Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
²²⁵Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
²²⁶Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
²²⁷Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
²²⁸Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
²²⁹Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
²³⁰School of Medicine, National University of Ireland, Galway, Ireland.
²³¹Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
²³²Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
²³³Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
²³⁴Institute of Biochemistry and Genetics, Ufa Scientific Center of the Russian Academy of Sciences, Ufa, Russian Federation.
²³⁵Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
²³⁶Department of Obstetrics and Gynaecology and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.
²³⁷Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
²³⁸Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, Greece.
²³⁹Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.
²⁴⁰Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
²⁴¹Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
²⁴²Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong.
²⁴³Department of Pathology, University Hospital of Region Zealand, Division Slagelse, Slagelse, Denmark.
²⁴⁴Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel.
²⁴⁵Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
²⁴⁶Vesalius Research Center, VIB, Leuven, Belgium.
²⁴⁷Clalit National Cancer Control Center, Haifa, Israel.
²⁴⁸Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France.
²⁴⁹Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Barcelona, Spain.
²⁵⁰University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
²⁵¹Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
²⁵²Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
²⁵³Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
²⁵⁴Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Republic of Korea.
²⁵⁵Department of Surgery, Soonchunhyang University and Hospital, Seoul, Republic of Korea.
²⁵⁶Clalit National Cancer Control Center, Haifa, Israel.
²⁵⁷Institut Curie, Paris, France.
²⁵⁸Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
²⁵⁹Department of Health Sciences Research, Mayo Clinic, Scottsdale, Arizona, USA.
²⁶⁰Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
²⁶¹Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
²⁶²Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
²⁶³Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
²⁶⁴German Breast Group, Neu Isenburg, Germany.
²⁶⁵Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
²⁶⁶Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, USA.
²⁶⁷Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
²⁶⁸Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
²⁶⁹Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
²⁷⁰Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
²⁷¹Southampton Clinical Trials Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
²⁷²Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
²⁷³Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Macedonian Academy of Sciences and Arts, Skopje, Macedonia.
²⁷⁴Division of Public Health Sciences, Epidemiology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
²⁷⁵Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori (INT), Milan, Italy.
²⁷⁶Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
²⁷⁷Department of Oncology, Pathology, Karolinska Institutet, Stockholm, Sweden.
²⁷⁸Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
²⁷⁹Moores Cancer Center, University of California, San Diego, La Jolla, California, USA.
²⁸⁰Division of Molecular and Clinical Epidemiology, Aichi Cancer Center Research Institute, Nagoya, Japan.
²⁸¹Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece.
²⁸²Lyon Neuroscience Research Center-CRNL, INSERM U1028, CNRS UMR 5292, University of Lyon, Lyon, France.
²⁸³Anatomical Pathology, Alfred Hospital, Melbourne, Victoria, Australia.
²⁸⁴Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands.
²⁸⁵Servicio de Anatomía Patológica, Hospital Monte Naranco, Oviedo, Spain.
²⁸⁶Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
²⁸⁷Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
²⁸⁸NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, New York, USA.
²⁸⁹School of Medicine, National University of Ireland, Galway, Ireland.
²⁹⁰Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
²⁹¹Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), IRCCS, Padua, Italy.
²⁹²Institute of Population Health, University of Manchester, Manchester, UK.
²⁹³Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
²⁹⁴Université Paris Sorbonne Cité, INSERM UMRS 1147, Paris, France.
²⁹⁵City of Hope Clinical Cancer Genomics Community Research Network, Duarte, California, USA.
²⁹⁶Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
²⁹⁷Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA.
²⁹⁸Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
²⁹⁹Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
³⁰⁰Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
³⁰¹Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
³⁰²Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
³⁰³Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
³⁰⁴Department of Medicine, University of California, San Francisco,San Francisco, California, USA.
³⁰⁵Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
³⁰⁶Center for Clinical Cancer Genetics and Global Health, University of Chicago, Chicago, Illinois, USA.
³⁰⁷Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
³⁰⁸Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
³⁰⁹West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK.
³¹⁰Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
³¹¹Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
³¹²Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain.
³¹³University of New Mexico Health Sciences Center, University of New Mexico, Albuquerque, New Mexico, USA.
³¹⁴Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy.
³¹⁵Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
³¹⁶Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
³¹⁷Curtin UWA Centre for Genetic Origins of Health and Disease, Curtin University and University of Western Australia, Perth, Western Australia, Australia.
³¹⁸Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
³¹⁹Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori (INT), Milan, Italy.
³²⁰Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
³²¹Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain.
³²²IFOM, FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy.
³²³Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
³²⁴Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
³²⁵Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
³²⁶Clalit National Cancer Control Center, Haifa, Israel.
³²⁷Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Macedonian Academy of Sciences and Arts, Skopje, Macedonia.
³²⁸Center for Medical Genetics, Ghent University, Ghent, Belgium.
³²⁹South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, UK.
³³⁰Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
³³¹Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK.
³³²Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, Russian Federation.
³³³Center for Inherited Disease Research (CIDR), Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
³³⁴ProCURE, Catalan Institute of Oncology, IDIBELL (Bellvitge Biomedical Research Institute), Barcelona, Spain.
³³⁵Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.
³³⁶Department of Gynecology and Obstetrics, Ludwig Maximilians University of Munich, Munich, Germany.
³³⁷Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori (INT), Milan, Italy.
³³⁸Section of Cancer Genetics, The Institute of Cancer Research, London, UK.
³³⁹Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
³⁴⁰Department of Obstetrics and Gynaecology and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.
³⁴¹Clalit National Cancer Control Center, Haifa, Israel.
³⁴²Clalit National Cancer Control Center, Haifa, Israel.
³⁴³Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
³⁴⁴Center for Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
³⁴⁵Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
³⁴⁶Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, Illinois, USA.
³⁴⁷Medical Oncology Department, CIBERONC, Hospital Clínico San Carlos, Madrid, Spain.
³⁴⁸Center for Inherited Disease Research (CIDR), Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
³⁴⁹Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
³⁵⁰Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
³⁵¹Institute of Pathology, Staedtisches Klinikum Karlsruhe, Karlsruhe, Germany.
³⁵²Hereditary Cancer Clinic, University Hospital of Heraklion, Heraklion, Greece.
³⁵³Department of Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
³⁵⁴Epidemiology Branch, National Institute of Environmental Health Sciences, US National Institutes of Health, Research Triangle Park, North Carolina, USA.
³⁵⁵National Cancer Institute, Bangkok, Thailand.
³⁵⁶Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA.
³⁵⁷Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
³⁵⁸Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
³⁵⁹Research Oncology, Guy's Hospital, King's College London, London, UK.
³⁶⁰Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
³⁶¹Department of Gynaecology and Obstetrics, University of Ulm, Ulm, Germany.
³⁶²Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
³⁶³Division of Molecular Medicine, Pathology North, John Hunter Hospital, Newcastle, New South Wales, Australia.
³⁶⁴Section of Cancer Genetics, The Institute of Cancer Research, London, UK.
³⁶⁵Clinical Cancer Genetics Program, Division of Human Genetics, Department of Internal Medicine, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
³⁶⁶Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
³⁶⁷Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
³⁶⁸Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
³⁶⁹School of Public Health, China Medical University, Taichung, Taiwan.
³⁷⁰Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
³⁷¹Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
³⁷²Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
³⁷³Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
³⁷⁴North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, UK.
³⁷⁵Department of Obstetrics and Gynaecology and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.
³⁷⁶National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
³⁷⁷Department of Pathology, University of Melbourne, Melbourne, Victoria, Australia.
³⁷⁸Cancer Control Research, BC Cancer Agency, Vancouver, British Columbia, Canada.
³⁷⁹Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
³⁸⁰Saarland Cancer Registry, Saarbrücken, Germany.
³⁸¹Service de Génétique Oncologique and INSERM U830, Institut Curie, Paris, France - Université Paris Descartes, Sorbonne Paris Cité.
³⁸²Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
³⁸³Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
³⁸⁴Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.
³⁸⁵Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
³⁸⁶National Human Genome Research Institute, US National Institutes of Health, Bethesda, Maryland, USA.
³⁸⁷Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
³⁸⁸Department of Obstetrics and Gynaecology and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.
³⁸⁹Epidemiology Branch, National Institute of Environmental Health Sciences, US National Institutes of Health, Research Triangle Park, North Carolina, USA.
³⁹⁰Molecular Genetics Laboratory, Clinical Genetics Service, Cruces University Hospital and BioCruces Health Research Institute, Barakaldo, Spain.
³⁹¹Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.
³⁹²Cancer Research Malaysia, Subang Jaya, Malaysia.
³⁹³Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
³⁹⁴McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada.
³⁹⁵Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Barcelona, Spain.
³⁹⁶Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
³⁹⁷Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
³⁹⁸Ospedale di Circolo ASST Settelaghi, Varese, Italy.
³⁹⁹Latvian Biomedical Research and Study Centre, Riga, Latvia.
⁴⁰⁰Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, Québec, Canada.
⁴⁰¹Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
⁴⁰²Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
⁴⁰³Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
⁴⁰⁴Center for Cancer Epidemiology and Prevention, University of Chicago, Chicago, Illinois, USA.
⁴⁰⁵Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁴⁰⁶Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Québec, Canada.
⁴⁰⁷Cancer and Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.
⁴⁰⁸Hereditary Cancer Clinic, Department of Medical Oncology, Prince of Wales Hospital, Randwick, New South Wales, Australia.
⁴⁰⁹Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
⁴¹⁰Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
⁴¹¹Frauenklinik der Stadtklinik Baden Baden, Baden Baden, Germany.
⁴¹²Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
⁴¹³Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
⁴¹⁴Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
⁴¹⁵Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands.
⁴¹⁶Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa.
⁴¹⁷Unit of Hereditary Cancer, Department of Epidemiology, Prevention and Special Functions, IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) AOU San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.
⁴¹⁸Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Berlin, Germany.
⁴¹⁹Fundación Pública Galega de Medicina Xenómica, Servizo Galego de Saúde SERGAS, Instituto de Investigaciones Sanitarias (IDIS), Santiago de Compostela, Spain.
⁴²⁰Unit of Functional Onco-genomics and Genetics, CRO Aviano, National Cancer Institute, Aviano, Italy.
⁴²¹Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
⁴²²McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada.
⁴²³Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
⁴²⁴Oxford Regional Genetics Service, Churchill Hospital, Oxford, UK.
⁴²⁵Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
⁴²⁶Department of Gynaecology and Obstetrics, University of Ulm, Ulm, Germany.
⁴²⁷Center for Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
⁴²⁸Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, US National Institutes of Health, Research Triangle Park, North Carolina, USA.
⁴²⁹Clinical Cancer Genetics, City of Hope, Duarte, California, USA.
⁴³⁰Department of Oncology, Pathology, Karolinska Institutet, Stockholm, Sweden.
⁴³¹Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
⁴³²Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, USA.
⁴³³Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
⁴³⁴Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
⁴³⁵Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.
⁴³⁶Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
⁴³⁷Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
⁴³⁸Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
⁴³⁹Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
⁴⁴⁰Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, Greece.
⁴⁴¹Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori (INT), Milan, Italy.
⁴⁴²Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
⁴⁴³Cancer Genomics Research Laboratory (CGR), Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
⁴⁴⁴Department of Epidemiology, University of California, Irvine, Irvine, California, USA.
⁴⁴⁵Department of Medicine, Institute for Human Genetics, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA.
⁴⁴⁶Ospedale di Circolo ASST Settelaghi, Varese, Italy.
⁴⁴⁷Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servizo Galego de Saúde SERGAS, Santiago de Compostela, Spain.
⁴⁴⁸Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.
⁴⁴⁹Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
⁴⁵⁰Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
⁴⁵¹Curtin UWA Centre for Genetic Origins of Health and Disease, Curtin University and University of Western Australia, Perth, Western Australia, Australia.
⁴⁵²Clinical Genetics Research Laboratory, Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
⁴⁵³Department of Molecular Medicine, University La Sapienza, Rome, Italy.
⁴⁵⁴Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
⁴⁵⁵Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
⁴⁵⁶Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁴⁵⁷Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany.
⁴⁵⁸Center for Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
⁴⁵⁹Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Québec, Canada.
⁴⁶⁰Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
⁴⁶¹Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
⁴⁶²Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
⁴⁶³Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
⁴⁶⁴Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
⁴⁶⁵Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
⁴⁶⁶Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
⁴⁶⁷Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
⁴⁶⁸Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
⁴⁶⁹Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Québec, Canada.